SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cistron Biotechnology(CIST)$.30 -- Ignore unavailable to you. Want to Upgrade?


To: Rudy Saucillo who wrote (2288)6/5/1999 4:55:00 PM
From: Walter Morton  Respond to of 2742
 
Follow the link.



To: Rudy Saucillo who wrote (2288)6/5/1999 5:54:00 PM
From: Steve Harmon  Read Replies (2) | Respond to of 2742
 
Spin of IL-1 AND sell Cist's cash to the highest bidder for 65-70 cent a share.

This was presented to Bruce Galton by Bluestone Capital a year and a half ago.

He turned the idea down.

Shareholders would have been winners.

Instead more dilution, lavish salaries, and 1 year paid vacations were dished out.



To: Rudy Saucillo who wrote (2288)6/7/1999 7:14:00 PM
From: Walter Morton  Read Replies (1) | Respond to of 2742
 
So Rudy, are you saying that the agreement with PMC that could generate $31 million plus royalties is only worth about $.30?



To: Rudy Saucillo who wrote (2288)6/7/1999 11:41:00 PM
From: Walter Morton  Respond to of 2742
 
Does this company have a good management team?

genzyme.com

Would it be interested in CIST?